PubRank
Search
About
Arnold Markoe
Author PubWeight™ 14.42
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.
Blood
2005
1.38
2
Spinal cord gliomas: A multi-institutional retrospective analysis.
Int J Radiat Oncol Biol Phys
2005
1.37
3
Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.
Cancer
2012
0.97
4
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
Arch Ophthalmol
2003
0.93
5
Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.
Br J Haematol
2010
0.91
6
Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.
Int J Radiat Oncol Biol Phys
2012
0.91
7
Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Int J Radiat Oncol Biol Phys
2007
0.90
8
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma.
Clin Ophthalmol
2013
0.88
9
Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes.
Ophthalmology
2004
0.87
10
Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.
Am J Clin Oncol
2006
0.83
11
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Int J Radiat Oncol Biol Phys
2002
0.80
12
Extended remission of a recurrent median nerve malignant peripheral nerve sheath tumor after multimodal treatment. Case report.
J Neurosurg
2005
0.79
13
Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma.
Am J Clin Oncol
2005
0.79
14
Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol.
Am J Clin Oncol
2005
0.78
15
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors.
J Neurooncol
2006
0.78
16
Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
J Neurooncol
2004
0.76
17
University of Miami experience using one versus two intracavitary brachytherapy implants.
Am J Clin Oncol
2002
0.75
18
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.
Semin Radiat Oncol
2002
0.75
19
Leptomeningeal failure of retinoblastoma.
Pediatr Blood Cancer
2014
0.75